LINDEE ALLEN: Open Payments
NPI 1194038489 · BRIGHAM CITY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$457 in 33 payments from 9 companies in 2025. Trend: 2023 $702 · 2024 $561 · 2025 $457
Food & beverage: $457
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $252 |
| PFIZER INC. | 4 | $72 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $34 |
| Astellas Pharma US Inc | 1 | $31 |
| Janssen Pharmaceuticals, Inc | 1 | $16 |
| Amgen Inc. | 1 | $14 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
| Lundbeck LLC | 1 | $14 |
| Organon LLC | 1 | $12 |
Products named: VRAYLAR, QULIPTA, NURTEC ODT, CAPLYTA, Veozah, UBRELVY, SPRAVATO, OTEZLA.
Industry payments across UT — which companies pay providers there.
